| Role of B cells as antigen presenting cells I Rastogi, D Jeon, JE Moseman, A Muralidhar, HK Potluri, DG McNeel Frontiers in immunology 13, 954936, 2022 | 85 | 2022 |
| DNA area and NETosis analysis (DANA): a high-throughput method to quantify neutrophil extracellular traps in fluorescent microscope images R Rebernick, L Fahmy, C Glover, M Bawadekar, D Shim, CL Holmes, ... Biological procedures online 20, 1-9, 2018 | 58 | 2018 |
| Treatment combinations with DNA vaccines for the treatment of metastatic castration-resistant prostate cancer (mCRPC) M Gamat-Huber, D Jeon, LE Johnson, JE Moseman, A Muralidhar, ... Cancers 12 (10), 2831, 2020 | 17 | 2020 |
| Ordered patterning of the sensory system is susceptible to stochastic features of gene expression R Giri, DK Papadopoulos, DM Posadas, HK Potluri, P Tomancak, M Mani, ... Elife 9, e53638, 2020 | 15 | 2020 |
| Antitumor efficacy of 90Y-NM600 targeted radionuclide therapy and PD-1 blockade is limited by regulatory T cells in murine prostate tumors HK Potluri, CA Ferreira, J Grudzinski, C Massey, E Aluicio-Sarduy, ... Journal for Immunotherapy of Cancer 10 (8), 2022 | 14 | 2022 |
| Antibody profiling of patients with prostate cancer reveals differences in antibody signatures among disease stages HK Potluri, TL Ng, MA Newton, J Zhang, CA Maher, PS Nelson, ... Journal for Immunotherapy of Cancer 8 (2), 2020 | 13 | 2020 |
| GM-CSF elicits antibodies to tumor-associated proteins when used as a prostate cancer vaccine adjuvant HK Potluri, TL Ng, MA Newton, DG McNeel Cancer Immunology, Immunotherapy 71 (9), 2267-2275, 2022 | 6 | 2022 |
| Targeted Radiation and Immune Therapies—Advances and Opportunities for the Treatment of Prostate Cancer A Muralidhar, HK Potluri, T Jaiswal, DG McNeel Pharmaceutics 15 (1), 252, 2023 | 5 | 2023 |
| Profound immunomodulatory effects of 225Ac-NM600 drive enhanced anti-tumor response in prostate cancer CA Ferreira, HK Potluri, C Massey, JJ Grudzinski, A Carston, N Clemons, ... bioRxiv, 2022.09. 26.509374, 2022 | 2 | 2022 |
| Low-dose TRT reshapes the microenvironment of prostate tumors to potentiate response to immunotherapy R Hernandez, H Potluri, E Aluicio-Sarduy, J Grudzinski, C Massey, ... Journal of Nuclear Medicine 61 (supplement 1), 36-36, 2020 | 2 | 2020 |
| Molecularly targeted radionuclide therapy modulates the composition of the murine prostate cancer microenvironment H Potluri, R Hernandez, C Zahm, J Grudzinski, C Massey, J Weichert, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 7, 2019 | 2 | 2019 |
| Stochastic gene expression is optimized to drive developmental self-organization R Giri, DK Papadopoulos, DM Posadas, HK Potluri, P Tomancak, M Mani, ... Free radical biology & medicine., 2019 | 2 | 2019 |
| 16 Antibody profiling of prostate cancer patients reveals differences in antibody signatures among disease stages and following treatment H Potluri, TL Ng, M Newton, J Zhang, C Maher, P Nelson, D McNeel Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | 1 | 2020 |
| Ordered patterning of the sensory system is susceptible to stochastic features of gene expression R Giri, DK Papadopoulos, DM Posadas, HK Potluri, P Tomancak, M Mani, ... bioRxiv, 546911, 2019 | 1 | 2019 |
| 870 High-dose radiation is required for effective combination with tumor-specific vaccination in a prostate cancer model H Potluri, C Ferreira, J Grudzinski, C Massey, R Hernandez, J Weichert, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| Immunological effects drive efficacy differences of alpha vs. beta radiopharmaceutical agents in prostate cancer R Hernandez, CA Ferreira, H Potluri, C Massey, Z Rosenkrans, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 49 (SUPPL 1 …, 2022 | | 2022 |
| Targeted Alpha vs Beta Therapy with 225Ac/177Lu-NM600 for Castration-Resistant Prostate Cancer C Ferreira, H Potluri, C Massey, Z Rosenkrans, C Choi, E Aluicio-Sarduy, ... Journal of Nuclear Medicine 63 (supplement 2), 2302-2302, 2022 | | 2022 |
| Combination Targeted Radionuclide Therapy and Immunotherapy for Prostate Cancer HK Potluri The University of Wisconsin-Madison, 2022 | | 2022 |
| 594 Combination of antigen-specific vaccination and targeted radionuclide therapy improves anti-tumor efficacy in a murine prostate model H Potluri, C Ferreira, J Grudzinski, C Massey, R Hernandez, J Weichert, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), A624-A624, 2021 | | 2021 |
| Low-dose targeted radionuclide therapy has favorable local and systemic effects on immune populations in a murine prostate cancer model HK Potluri, R Hernandez, CD Zahm, J Grudzinski, C Massey, J Weichert, ... Cancer Research 80 (16_Supplement), 2262-2262, 2020 | | 2020 |
